Medicare Enrolled
Dr. Sumul Raval, M.D.
Neurology · West Long Branch, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Raval from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raval?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Raval
Dr. Sumul Raval is a neurology specialist in West Long Branch, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Raval performed 8,490 Medicare services across 3,790 unique beneficiaries.
Between the years covered by Open Payments, Dr. Raval received a total of $20,964 from 63 pharmaceutical and/or device companies across 333 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Raval is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 10% volume in NJ
$20,964 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,490
Medicare services
Top 10% in NJ for neurology
3,790
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~424 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
5,118 | $66 | $200 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
913 | $107 | $300 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
780 | $98 | $250 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
679 | $99 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
241 | $142 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
226 | $143 | $302 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
75 | $183 | $400 |
| Ultrasound of brain blood flow An ultrasound test used to examine blood flow within the brain to check for blood clots. |
75 | $143 | $400 |
| EEG brain wave monitoring, 41-60 minutes This procedure involves monitoring and recording electrical activity in the brain using electrodes placed on the scalp for a duration of 41 to 60 minutes. |
70 | $294 | $550 |
| Digital analysis of brain wave activity (EEG) This procedure involves the digital analysis of brain wave activity recorded via an electroencephalogram (EEG). It focuses on the technical interpretation of the digital data rather than the initial recording or supervision. |
70 | $241 | $700 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $108 | $350 |
| New patient office visit, complex (60-74 min) | 63 | $180 | $500 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
58 | $78 | $350 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
58 | $175 | $650 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,964
Total received (2018-2024)
Avg $2,995/year across 7 years
Top 16% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
333
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,672 (74.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,931 (18.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,361 (6.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,644
2023
$785
2022
$2,507
2021
$6,243
2020
$4,563
2019
$1,022
2018
$4,200
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ACADIA Pharmaceuticals Inc
$238
PFIZER INC.
$190
Eisai Inc.
$158
ANI Pharmaceuticals, Inc.
$86
ABBVIE INC.
$80
Novocure Inc.
$78
Medtronic, Inc.
$78
Lilly USA, LLC
$67
CSL Behring
$55
CATALYST PHARMACEUTICALS, INC.
$50
Alexion Pharmaceuticals, Inc.
$46
Biogen, Inc.
$45
Teva Pharmaceuticals USA, Inc.
$44
Aucta Pharmaceuticals, Inc.
$40
UCB, Inc.
$35
Avadel CNS Pharmaceuticals, LLC
$35
Amgen Inc.
$34
Azurity Pharmaceuticals, Inc.
$34
SERVIER PHARMACEUTICALS LLC
$33
Alnylam Pharmaceuticals Inc.
$33
Merck Sharp & Dohme LLC
$32
Sumitomo Pharma America, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$26
Vanda Pharmaceuticals Inc.
$18
Life Molecular Imaging Ltd
$16
Celgene Corporation
$16
Octapharma USA, Inc.
$15
Neurocrine Biosciences, Inc.
$15
Grifols USA, LLC
$14
Top 3 companies account for 35.7% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$5,727
Allergan, Inc.
$4,595
ABBVIE INC.
$2,636
Mallinckrodt LLC
$2,005
Novocure Inc.
$1,670
Teva Pharmaceuticals USA, Inc.
$567
PFIZER INC.
$335
Biogen, Inc.
$329
ACADIA Pharmaceuticals Inc
$293
Alexion Pharmaceuticals, Inc.
$272
Eisai Inc.
$200
Lilly USA, LLC
$195
UCB, Inc.
$161
Novartis Pharmaceuticals Corporation
$155
ANI Pharmaceuticals, Inc.
$121
Supernus Pharmaceuticals, Inc.
$97
Sumitomo Pharma America, Inc.
$96
Boston Scientific Corporation
$83
Medtronic, Inc.
$78
Amgen Inc.
$76
Sunovion Pharmaceuticals Inc.
$65
Celgene Corporation
$61
EMD Serono, Inc.
$57
Bayer HealthCare Pharmaceuticals Inc.
$56
CSL Behring
$55
US WorldMeds, LLC
$55
Upsher-Smith Laboratories LLC
$52
CATALYST PHARMACEUTICALS, INC.
$50
Mallinckrodt Enterprises LLC
$45
Mitsubishi Tanabe Pharma America, Inc.
$42
Aucta Pharmaceuticals, Inc.
$40
GENZYME CORPORATION
$40
Avanir Pharmaceuticals, Inc.
$39
Avadel CNS Pharmaceuticals, LLC
$35
Azurity Pharmaceuticals, Inc.
$34
SERVIER PHARMACEUTICALS LLC
$33
Alnylam Pharmaceuticals Inc.
$33
Merck Sharp & Dohme LLC
$32
Mallinckrodt Hospital Products Inc.
$30
Adamas Pharmaceuticals, Inc.
$29
EISAI INC.
$29
Takeda Pharmaceuticals U.S.A., Inc.
$26
Genentech USA, Inc.
$24
Merz North America, Inc.
$24
SK Life Science, Inc.
$21
Esperion Therapeutics, Inc.
$18
Amylyx Pharmaceuticals, Inc.
$18
Vanda Pharmaceuticals Inc.
$18
Cumberland Pharmaceuticals, Inc.
$17
Life Molecular Imaging Ltd
$16
ARGENX US, INC.
$16
Octapharma USA, Inc.
$15
Neurocrine Biosciences, Inc.
$15
Kyowa Kirin, Inc.
$15
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
Acorda Therapeutics, Inc
$14
Grifols USA, LLC
$14
Allergan Inc.
$14
Akcea Therapeutics, Inc.
$14
Bausch Health US, LLC
$14
Helsinn Therapeutics (U.S.), Inc.
$12
Biohaven Pharmaceutical Holding Company Ltd.
$12
Zyla Life Sciences
$11
Top 3 companies account for 61.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AFINITOR · AIMOVIG · AJOVY · AKYNZEO · AMVUTTRA · AMYVID · APOKYN · APTIOM · AUSTEDO · AVONEX · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · COPAXONE · EMGALITY · FYCOMPA · Fycompa · GILENYA · GOCOVRI · Gamunex-C · HORIZANT · HYQVIA · Hizentra · INBRIJA · INGREZZA · INTELLIS ADAPTIVESTIM · LEMTRADA · LUMRYZ · Leqembi · MIGRANAL · MYOBLOC · Mavenclad · Motpoly XR · NEURACEQ · NEXLIZET · NUEDEXTA · NUPLAZID · NURTEC ODT · Neupro · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · Oncology · Optune · PANZYGA · PONVORY · POTELIGEO · PURIFIED CORTROPHIN GEL · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QULIPTA · RADICAVA · RELYVRIO · Radicava · Rystiggo · SANCUSO · SOLIRIS · SPRIX · SUPERION · Soliris · TECFIDERA · TEGSEDI · TOPIRAMATE Extended Release Capsules · TROKENDI XR · TYSABRI · Tibsovo · Tosymra Sumatriptan Nasal Spray · UBRELVY · ULTOMIRIS · UPLIZNA · VANTA ADAPTIVESTIM · VUMERITY · VYVGART HYTRULO · Vimpat · Voranigo · WELIREG · XEOMIN · Xadago · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (75%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Neurologists within 10 mi
139
Per 100K population
21.6
County median income
$122,727
Nearest hospital
MONMOUTH MEDICAL CENTER
1.7 mi
1.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Raval is a mixed practice specialist, with above-average Medicare volume (top 10% in NJ), with speaking/promotional industry engagement in the top 16% of NJ peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Raval experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Raval performed 5,118 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Raval receive payments from pharmaceutical companies?
Yes. Dr. Raval received a total of $20,964 from 63 companies across 333 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raval's costs compare to other neurologists in West Long Branch?
Dr. Raval's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raval) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in West Long Branch
Browse neurologists in West Long Branch ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology